199 related articles for article (PubMed ID: 14566830)
1. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.
Bruner DW; Moore D; Parlanti A; Dorgan J; Engstrom P
Int J Cancer; 2003 Dec; 107(5):797-803. PubMed ID: 14566830
[TBL] [Abstract][Full Text] [Related]
2. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
Kiciński M; Vangronsveld J; Nawrot TS
PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
[TBL] [Abstract][Full Text] [Related]
3. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.
Ren ZJ; Cao DH; Zhang Q; Ren PW; Liu LR; Wei Q; Wei WR; Dong Q
BMC Cancer; 2019 Sep; 19(1):871. PubMed ID: 31477094
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer risk prediction based on complete prostate cancer family history.
Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
[TBL] [Abstract][Full Text] [Related]
5. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
6. Family history and prostate cancer risk in a population-based cohort of Iowa men.
Cerhan JR; Parker AS; Putnam SD; Chiu BC; Lynch CF; Cohen MB; Torner JC; Cantor KP
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):53-60. PubMed ID: 9950240
[TBL] [Abstract][Full Text] [Related]
7. Family history and the risk of breast cancer: a systematic review and meta-analysis.
Pharoah PD; Day NE; Duffy S; Easton DF; Ponder BA
Int J Cancer; 1997 May; 71(5):800-9. PubMed ID: 9180149
[TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of familial prostate cancer risk.
Johns LE; Houlston RS
BJU Int; 2003 Jun; 91(9):789-94. PubMed ID: 12780833
[TBL] [Abstract][Full Text] [Related]
12. First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer.
Zheng Q; Ying Q; Ren Z; Zhang Q; Lu D; Wang H; Wei W
Medicine (Baltimore); 2021 Jan; 100(4):e23816. PubMed ID: 33530178
[TBL] [Abstract][Full Text] [Related]
13. Family history and risk of fatal prostate cancer.
Rodríguez C; Calle EE; Miracle-McMahill HL; Tatham LM; Wingo PA; Thun MJ; Heath CW
Epidemiology; 1997 Nov; 8(6):653-7. PubMed ID: 9345665
[TBL] [Abstract][Full Text] [Related]
14. Family history and the risk of prostate cancer.
Steinberg GD; Carter BS; Beaty TH; Childs B; Walsh PC
Prostate; 1990; 17(4):337-47. PubMed ID: 2251225
[TBL] [Abstract][Full Text] [Related]
15. Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death.
Albright FS; Stephenson RA; Agarwal N; Cannon-Albright LA
Prostate; 2017 Jan; 77(1):41-48. PubMed ID: 27527734
[TBL] [Abstract][Full Text] [Related]
16. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
Zeegers MP; Jellema A; Ostrer H
Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
[TBL] [Abstract][Full Text] [Related]
17. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
Clements MB; Vertosick EA; Guerrios-Rivera L; De Hoedt AM; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Haese A; Montorsi F; Boorjian SA; Poyet C; Ankerst DP; Vickers AJ
Eur Urol; 2022 Aug; 82(2):163-169. PubMed ID: 34980493
[TBL] [Abstract][Full Text] [Related]
18. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
Cannon-Albright LA; Carr SR; Akerley W
J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
[TBL] [Abstract][Full Text] [Related]
19. Age at diagnosis and age at death in familial prostate cancer.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
[TBL] [Abstract][Full Text] [Related]
20. Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy.
Bova GS; Partin AW; Isaacs SD; Carter BS; Beaty TL; Isaacs WB; Walsh PC
J Urol; 1998 Sep; 160(3 Pt 1):660-3. PubMed ID: 9720516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]